559 filings
3
Michael P Dube
22 Apr 24
Intellia Therapeutics / Michael P Dube ownership change
4:10pm
PRE 14A
NTLA
Intellia Therapeutics Inc
Preliminary proxy
16 Apr 24
4:10pm
8-K
NTLA
Intellia Therapeutics Inc
15 Apr 24
Departure of Directors or Certain Officers
4:21pm
8-K
NTLA
Intellia Therapeutics Inc
22 Mar 24
Termination of a Material Definitive Agreement
9:26am
4
Laura Sepp-Lorenzino
5 Mar 24
Intellia Therapeutics / Laura Sepp-Lorenzino ownership change
4:10pm
4
NTLA
Intellia Therapeutics Inc
5 Mar 24
Intellia Therapeutics / JAMES BASTA ownership change
4:10pm
4
NTLA
Intellia Therapeutics Inc
5 Mar 24
Intellia Therapeutics / Derek Hicks ownership change
4:10pm
4
NTLA
Intellia Therapeutics Inc
5 Mar 24
Intellia Therapeutics / Eliana Clark ownership change
4:10pm
4
NTLA
Intellia Therapeutics Inc
5 Mar 24
Intellia Therapeutics / JOHN M LEONARD ownership change
4:10pm
4
David Lebwohl
5 Mar 24
Intellia Therapeutics / David Lebwohl ownership change
4:10pm
4
Glenn Goddard
5 Mar 24
Intellia Therapeutics / Glenn Goddard ownership change
4:10pm
424B5
NTLA
Intellia Therapeutics Inc
26 Feb 24
Prospectus supplement for primary offering
7:04am
424B5
NTLA
Intellia Therapeutics Inc
23 Feb 24
Prospectus supplement for primary offering
5:22pm
8-K
NTLA
Intellia Therapeutics Inc
23 Feb 24
Amendment No. 1 to the Open Market Sale Agreementsm
5:17pm
S-8
NTLA
Intellia Therapeutics Inc
22 Feb 24
Registration of securities for employees
4:11pm
10-K
2023 FY
NTLA
Intellia Therapeutics Inc
Annual report
22 Feb 24
4:02pm
8-K
NTLA
Intellia Therapeutics Inc
22 Feb 24
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
7:45am
SC 13G/A
NTLA
Intellia Therapeutics Inc
13 Feb 24
Intellia Therapeutics / VANGUARD ownership change
5:07pm
8-K
NTLA
Intellia Therapeutics Inc
1 Feb 24
Regulation FD Disclosure
4:05pm
SC 13G/A
ARK Investment Management LLC
29 Jan 24
Intellia Therapeutics / ARK Investment Management ownership change
4:00pm